AstraZeneca Seeks Edge Over Rivals in Severe Asthma Treatment

By Ben Hirschler LONDON – AstraZeneca hopes to convince doctors its experimental injection for severe asthma has an edge over two approved rivals after clinical trials data on Monday showed it worked well when given just once every two months. The drugmaker has previously flagged benralizumab, which is likely to reach the market next year,

[ Read More ]

New Incentives Needed to Develop Antibiotics to Fight Superbugs

By Bill Berkrot NEW YORK, May 29 – Drugmakers are renewing efforts to develop medicines to fight emerging antibiotic-resistant bacteria, but creating new classes of drugs on the scale needed is unlikely to happen without new financial incentives to make the effort worth the investment, companies and industry experts said. American military researchers on Thursday

[ Read More ]

Of Hope, and of IVF

One woman’s story of her struggle to conceive BY Jumana Al-Darwish In solitude, I await my turn calmly. I am in a state of trance. I sit staring out of the blinds in my hospital room. There’s not much longer to go; in less than 20 minutes, the miracle of science will allow three embryos

[ Read More ]